---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-041160"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2021-08-10T23:59:59+00:00"
generated_at: "2026-06-29T17:38:01.672693+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Emmaus restates 2020 financials; net income rises to $1.4M from $1.1M

## Summary
- Non-reliance on FY2020 financials due to equity method investment misstatement; restated 10-K/A filed with unqualified audit opinion.
- Net income restated to $1.4M from $1.1M; increase of $254K and $0.01 EPS from corrected equity in losses of Japanese affiliate EJ Holdings.
- Original audit opinion had qualification; now eliminated with complete audit of affiliate financials.
- Trading on OTC Pink could be suspended if Q1 and Q2 2021 10-Qs not filed by September 28, 2021; company striving to file promptly.
- Interim Endari® sales volumes previously reported; full Q1 and Q2 2021 results expected in upcoming 10-Q filings.

## SEC filing metadata
- accession: 0001213900-21-041160
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2021-08-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 4.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390021041160/0001213900-21-041160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390021041160/ea145361-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-041160
- JSON: https://secwatch.observer/filing/0001213900-21-041160.json
- Plain text: https://secwatch.observer/filing/0001213900-21-041160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.